Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Function (CSF) vs AREDS 2
Guardion Health Sciences, Inc. (GHSI)
Company Research
Source: GlobeNewswire
In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, improvements in visual function (CSF) in the Lumega-Z Group were statistically significant and definitive. The AREDS 2 Group showed no statistical change. San Diego, CA, May 09, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and testing technologies supported by evidence-based protocols, today announced the results of a study from research scientists at the Western University College of Optometry to clinically evaluate the visual benefits of the Company’s micronized liquid formula Lumega-Z as compared to the AREDS 2 softgel supplement in individuals with retinal drusen and at risk of developing Age-Related Macular Degeneration (AMD). Dr. David Evans, Ph.D., Guardion’s Chief Science Office
Show less
Read more
Impact Snapshot
Event Time:
GHSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GHSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GHSI alerts
High impacting Guardion Health Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GHSI
News
- Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023GlobeNewswire
- Guardion Health Sciences, Inc. (NASDAQ: GHSI) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?PR Newswire
GHSI
Sec Filings
- 4/9/24 - Form 8-K
- 4/8/24 - Form DEFM14A
- 4/3/24 - Form 3
- GHSI's page on the SEC website